Atlas Trials

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

Clinical trial NCT01877187 · COMPLETED

Trial details

NCT number
NCT01877187
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2013-04-01
Primary completion
2020-02-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.